文献速递肿瘤 PET/CT

肿瘤学中示踪剂动力学分析原理,第二部分:示例与未来方向

Principles of Tracer Kinetic Analysis in Oncology, Part II: Examples and Future Directions.
PubMed 文献 · J Nucl Med · 2022-01-01

本文是两部分继续教育综述的第二部分,通过代表性病例展示动力学建模在肿瘤影像中的优势,涵盖单组织室模型(15O-水)、不可逆双组织室模型(18F-FDG)和可逆双组织室模型(3'-脱氧-3'-18F-氟胸苷),并将动力学方法与临床常用的静态摄取指标进行对比。

要点

  • 动力学分析可估算与疾病相关的生物学过程,提供超越静态摄取的额外信息。
  • 本文示例包括15O-水单组织室模型、18F-FDG不可逆双组织室模型和18F-FLT可逆双组织室模型。
  • 动力学方法与临床常用静态摄取指标形成对比,有助于理解相关研究并改进临床核医学研究解读。

核心结论

  • 本两部分综述为读者提供动力学分析背景,以理解相关研究并改进以肿瘤影像为重点的临床核医学研究解读。

研究设计与样本

  • 本文为两部分继续教育综述的第二部分,通过代表性病例示例说明肿瘤学中动力学分析的原理与优势。

主要发现

  • 动态PET的动力学分析通过数学分析放射性示踪剂与组织的相互作用,可估算与疾病相关的生物学过程。
  • 本文回顾了第一部分讨论的模型类型示例:单组织室模型(15O-水)、不可逆双组织室模型(18F-FDG)和可逆双组织室模型(3'-脱氧-3'-18F-氟胸苷)。
  • 动力学方法与临床通常使用的静态摄取指标形成对比。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Learning Objectives: On successful completion of this activity, participants should be able to (1) describe examples of the application of PET tracer kinetic analysis to oncology; (2) list applications research and possible clinical applications in oncology where kinetic analysis is helpful; and (3) discuss future applications of kinetic modeling to cancer research and possible clinical cancer imaging practice.Financial Disclosure: This work was supported by KL2 TR001879, R01 CA211337, R01 CA113941, R33 CA225310, Komen SAC130060, R50 CA211270, and K01 DA040023. Dr. Pantel is a consultant or advisor for Progenics and Blue Earth Diagnostics and is a meeting participant or lecturer for Blue Earth Diagnostics. Dr. Mankoff is on the scientific advisory boards of GE Healthcare, Philips Healthcare, Reflexion, and ImaginAb and is the owner of Trevarx; his wife is the chief executive officer of Trevarx. The authors of this article have indicated no other relevant relationships that could be perceived as a real or apparent conflict of interest.CME Credit: SNMMI is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing education for physicians. SNMMI designates each JNM continuing education article for a maximum of 2.0 AMA PRA Category 1 Credits. Physicians should claim only credit commensurate with the extent of their participation in the activity. For CE credit, SAM, and other credit types, participants can access this activity through the SNMMI website (http://www.snmmilearningcenter.org) through April 2025.Kinetic analysis of dynamic PET imaging enables the estimation of biologic processes relevant to disease. Through mathematic analysis of the interactions of a radiotracer with tissue, information can be gleaned from PET imaging beyond static uptake measures. Part I of this 2-part continuing education paper reviewed the underlying principles and methodology of kinetic modeling. In this second part, the benefits of kinetic modeling for oncologic imaging are illustrated through representative case examples that demonstrate the principles and benefits of kinetic analysis in oncology. Examples of the model types discussed in part I are reviewed here: a 1-tissue-compartment model (15O-water), an irreversible 2-tissue-compartment model (18F-FDG), and a reversible 2-tissue-compartment model (3'-deoxy-3'-18F-fluorothymidine). Kinetic approaches are contrasted with static uptake measures typically used in the clinic. Overall, this 2-part review provides the reader with background in kinetic analysis to understand related research and improve the interpretation of clinical nuclear medicine studies with a focus on oncologic imaging.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Pantel AR, Viswanath V, Muzi M, et al. Principles of Tracer Kinetic Analysis in Oncology, Part II: Examples and Future Directions. J Nucl Med. 2022. PMID: 35361713. doi:10.2967/jnumed.121.263519

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。